Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy - Trial 2021-000708-39
Access comprehensive clinical trial information for 2021-000708-39 through Pure Global AI's free database. This phase not specified trial is sponsored by Rheinische Friedrich-Wilhelms-Universität Bonn and is currently status unknown. The study focuses on Glioblastoma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2021-000708-39
Trial Details
EU Clinical Trials Register • 2021-000708-39
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy
Study Focus
Sponsor & Location
Rheinische Friedrich-Wilhelms-Universität Bonn
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Malignant neoplasm of brain
Malignant neoplasm: Brain, unspecified
Mesothelioma
Malignant neoplasm: Brain stem
Malignant neoplasm: Overlapping lesion of brain
Data Source
EU Clinical Trials Register
2021-000708-39
Non-Device Trial